ABOUT ME

I am an M.D. candidate at UCSF (Class of 2028) and a public health graduate from UNC Chapel Hill (B.S., Health Policy and Management, 2024). My work sits at the crossroads of oncology, translational science, and product-focused digital health.

I have contributed to research spanning precision oncology, population oncology, and radiation oncology, with particular interests in diagnostics, pharmacology, genetics, and practical AI for clinicians and patients.

Beyond research, I focus on building tools that improve access to reliable health information for underserved communities.

EDUCATION

DOCTOR OF MEDICINE (M.D.)

University of California, San Francisco

2024 - 2028

B.S. PUBLIC HEALTH (HEALTH POLICY & MANAGEMENT)

University of North Carolina at Chapel Hill

2020 - 2024

SELECTED HONORS

Phi Beta Kappa • Robert E. McNair Scholar • Duke Amgen Scholar • Harvard BPH Summer Intern

OLEA HEALTH

I co-founded Olea Health to expand access to trusted health guidance in communities that are often underserved by traditional care systems.

Olea focuses on practical, patient-facing technology that connects people to up-to-date health education, care pathways, and navigation support, with a mission centered on global health access.

oleahealth.us Olea LinkedIn

PUBLICATIONS

Publication list organized from your Google Scholar profile.

Open Full Publication List

Large Language Models in Population Oncology

JCO Clinical Cancer Informatics (2025) • DOI: 10.1200/CCI-25-00112

Opportunities and Challenges for Patient-Derived Models of Brain Tumors

npj Precision Oncology (2025) • DOI: 10.1038/s41698-025-00832-w

Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for HCC

Journal of Hepatocellular Carcinoma (2024) • DOI: 10.2147/JHC.S447025

Automated Computer Vision and Dose-Response Modeling Improve Throughput and Accuracy of an Ex Vivo Functional Precision Medicine Platform

Scientific Reports (2026) • DOI: 10.1038/s41598-025-31666-y

Rapid Functional Drug Screening of Passage-Zero Patient Brain Tumor Tissues Ex Vivo: Results from a Clinical Feasibility Study

Research Square Preprint (2025) • DOI: 10.21203/rs.3.rs-7993619/v1

Symptomatic Radiation Necrosis After Concurrent Targeted Therapy and SRS

Journal of Neuro-Oncology (2026) • DOI: 10.1007/s11060-026-05450-5